| Schedule of computation of basic and diluted net (loss) income per share |
| | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | 2026 | | 2025 | | | 2026 | | 2025 | | | Numerator: | | | | | | | | | | | | | | | | | Net (loss) income, basic | | $ | (51,693) | | $ | 15,896 | | | | $ | 28,994 | | $ | 817,609 | | | Add: Interest expense, net of tax, on the Company's 2026 and 2031 Convertible Notes | | | — | | | 1,096 | | | | | 2,789 | | | 3,257 | | | Net (loss) income, diluted | | $ | (51,693) | | $ | 16,992 | | | | $ | 31,783 | | $ | 820,866 | | | Denominator: | | | | | | | | | | | | | | | | | Weighted-average number of shares outstanding, basic | | | 83,476,100 | | | 78,471,119 | | | | | 83,004,625 | | | 78,642,478 | | | Effect of dilutive securities: | | | | | | | | | | | | | | | | | Common stock issuable under the Company's equity incentive plans | | | — | | | 3,170,135 | | | | | 3,601,228 | | | 2,783,134 | | | Common stock issuable under the Company's 2026 and 2031 Convertible Notes | | | — | | | 5,474,115 | | | | | 5,647,822 | | | 5,474,115 | | | Weighted-average common shares outstanding, diluted | | | 83,476,100 | | | 87,115,369 | | | | | 92,253,675 | | | 86,899,727 | | | Net (loss) income per common share, basic | | $ | (0.62) | * | $ | 0.20 | | | | $ | 0.35 | | $ | 10.40 | | | Net (loss) income per common share, diluted | | $ | (0.62) | * | $ | 0.20 | | | | $ | 0.34 | | $ | 9.45 | | |
* In the three months ended September 30, 2026, the Company experienced a net loss and therefore did not report any dilutive share impact.
|
| Schedule of historical dilutive common share equivalents outstanding |
| | | | | | | | As of September 30, | | | | 2026 | | 2025 | | Stock options | | 875,727 | | 3,246,389 | | Unvested restricted stock units | | 5,100 | | 90,900 | | Unvested performance based restricted stock units | | 75,893 | | — | | Total | | 956,720 | | 3,337,289 | |
|